# REVEAL Biomarkers of Engraftment After Alternative Donor HSCT

> **NCT03541889** · PHASE1 · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 56 (estimated)

## Conditions studied

- Primary Graft Failure

## Interventions

- **DRUG:** FLT imaging and TK1 blood measurements

## Key facts

- **NCT ID:** NCT03541889
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-05
- **Primary completion:** 2026-11
- **Final completion:** 2027-11
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03541889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03541889, "REVEAL Biomarkers of Engraftment After Alternative Donor HSCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03541889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*